0210_HYPERTHERMIA & RADIATION IN COMBINATION_ A CLINICAL FRACTIONATION REGIME - 08.pdf

Embed Size (px)

Citation preview

  • 8/14/2019 0210_HYPERTHERMIA & RADIATION IN COMBINATION_ A CLINICAL FRACTIONATION REGIME - 08.pdf

    1/4

    Int. J. Radiation Oncology Biol. Phys. Vol. 6, pp. 867-870 Pergamo n Press Ltd. , 1980. Printed in the U.S.A. 036~3016/80/070867~)4502.00/0

    Brief Communication

    HYPERTHERMIA AND RADIATION IN COMBINATION:A CLINICAL FRACTIONATION REGIME

    IqAIM I. BICFtER, M.D., Ph.D., TALJIT S. SANDHU, Ph.D.,F~,ED W. HETZEL, Ph.D.

    Division o f Radia tion B iology and Physics, Depar tment of Therapeutic Radiology, H enry Ford Ho spita l , Detroit ,Michigan 4 82 0 2 .A fractionation regime has been devised and clinically tested to use a combination of hyp erthermia and low doseradiation therapy to treat tumors w ith a curative intent. Hyperthermia is induced using m icrowaves delivered to adefined tissue volum e through specially designed applicators. Frequencies of 2450 915 or 300 MHz are usedaccording to the desired pen etration depth. Each trea tment lasts for 90 minutes. The sk in is cooled by an air jet.Tissue temperature is kept at 45C w hen hyperthermia alone is used and at 42C in com bination with radiation.Patients are treated twice a week with 7 2 hour intervals between treatmen ts. The regime consists of 4 treatments ofhyperthermia alone followed b y a w eek of rest. Thereafter each hyperthermia treatment is preceded by a 400 radfraction of x-irradiation delivered in 4 combined treatments to a total of 1600 rad. This low total radiation doseallows retreatment of previously irradiated areas or organs. No toxicity induced b y this combination has be endetected even in areas previously radiated to high doses. Twenty-three patients have been entered into the protocolthat encompasses 37 treatment fields. Most tumors respond to treatment many of these with total disappearance;skin brain breast and spinal cord are amon g the treated areas. Melanom as and lymph omas are the most sensitivetumors sarcomas the most resistant; adeno and squamous cell carcinoma in between.Hypertherm ia Fractionatlon Ra diation therapy.

    INTRODUCTIONFor o ver one hundred years resul ts have been repor tedindicating that heat can modify tumor growth. Thepioneer e ffort of Busch3 in 186 6 verified the disappear-ance of a sarcoma in the fact of hyperpyrexia duringerysipelas. Bruns2 and Coley5 had similar o bservations indifferent types of tumors. The past decade has seen arenewed interest in hyperthermia; both in the laboratoryand in the clinic.Several investigators have reported cure attemptsusing hyper thermia in d ifferent form s.~13 Doss and co-workers89~7 used radiofrequency heat ing in anim al andhuman tumors wi th excel lent resu l ts; a m ethod that wasalso tested extensively by LeV een et al t4Recently, Horn-back et al.2 reported their experience with the use ofmicrowaves. Suit and Schwayder18 ~9 have reviewed thel i te ra ture o f recent exper iences in h yper thermia . S ui t18demonstrated experimentally that the tumor cure dose(TCDs0) values for thermally resistant tumors weresignificantly reduced, therefore advocating a combina-tion of hyperthermia and radiation therapy. Since theoxygen enhancement ratio (OER) for hyperthermic

    damage may be close to one there is a good possibilitythat the combination of x-irradiation and hyperthermiawill lead to a specific effect on the hypoxic cells in thetumors. W estra and Dewey2 also indicate that becausethe hyperthermic sensitivity of mammalian cells isgreater in the S p hase o f the cel l replication cycle, whichis a lso the mo st res is tant to x- i r radia t ion , th is could a lsolead to further enhancem ent of the therapeutic effect ofthe combined modalit~es. Dramatic changes in cellsurvival during hyperthermia have also been observedwhen the pH o f the cel ls is only s l ightly al tered.~ Crile6combined heat with radiation in the treatment of cancerof the rectum. He surgical ly pro ved that this com binationwas effective in eradication of metastases. Crile7 alsodemonstrated the effectiveness of hyperthermia in amouse sarcoma and the dependence of cure on thetemperature achieved and the length of the treatmentper iod . He a lso com bined radia t ion and hyper thermia inthe treatments of sarcoma in huma ns. ~ Cavaliere et al.4 5documented the effect of heat on tumor cells and thesparing of normal tissue in rats. In clinical studies,regional perfusion with heated blood between 41-43C

    Presented in par t a t Am erican Socie ty of Therapeutic Radi-ologists , New Orleans, October 1979.W ork suppo r ted in par t b y grant CA 257 80- 0 1 awarded bythe National Cancer Institute, Department of Health, Educa-t ion, and W elfare .Reprint requests to: Haim I . Bicher , M.D. , Ph.D.Accepted for publication 19 March 198 0.

    867

  • 8/14/2019 0210_HYPERTHERMIA & RADIATION IN COMBINATION_ A CLINICAL FRACTIONATION REGIME - 08.pdf

    2/4

    86 8 Radiat ion O ncology Biology Physicswas used in recurrent tumors of the extremities, espe-cia lly melanom as. Only 7 o f 22 pa t ients fa i led to sho w adefinite respo nse to this treatment.In this article we repo rt preliminary results of the useof a unique protocol designed to rationally combinedhyperthermia and radiation treatment modalities in acl in ica l se t ting . This protoco l has been des g ned to takeadvantage of known effects of hyperthermia either aloneor in combination with ionizing radiation. The tempera-tures employed and sequencing are based on dataobtained by many scientific and clinical investigators aswell as recent results obtained in our laboratory.~46-9,~ ~5 .~7 20 , . Sk in cool ing was implem ented to p reventnormal t i s sue dam age whenever po ss ible . The number offractions and the duration of each treatment was arbi-trarily chosen, tak ing into account factors such as patientcompliance, patient comfort and possible biologicalfactors including thermo tolerance, vascular respo nse andrepair . In addition, the total dose of radiation emp loyed issufficiently low to allow retreatment of previously irra-diated fields.

    MET H OD S AND MA T ER IAL SProtocol

    Localized hyperthermia is induced in all patients bymicrowave radiation employing direct contact applica-tors. The tumor size, location and depth determine theapp l ica tor s ize and microwave frequency (2450 , 915 or30 0 M Hz) tha t a re emp loyed . Heat is in i tia l ly appl ied tothe tumor in four fractions of 1~/2 hour duration atintervals of 72 hours. The temperature is monitored tomainta in the tumo r tempera ture a t 45C _+ 0.5C whilethe overlying, normal skin is simultaneously maintainedwith air cooling at or below 36C. Following these 4fractions the patient rests for one week. Finally, fourmore fractions of hyperthermia are given; this time incombination with radiation. Each of these 4 treatmentsconsists of a dose of 400 rad to the tumor immediatelyfo l lowed (

  • 8/14/2019 0210_HYPERTHERMIA & RADIATION IN COMBINATION_ A CLINICAL FRACTIONATION REGIME - 08.pdf

    3/4

    Hyperthermia fractionation regime H. I. BICHER et al. 869Table 2. Results

    37 Fie ldstreated 23 PatientsTotal response 25P ar tia l re sp o nse 1 1 (9 le ss th an

    2 m o n thfollow-up)No response Recurrence Lo ca lMarginalC om plicatio ns Sk in burnsGrand se izure

    22 (complete lyhealed) (Neck treatment)(epilepticpatient)

    the microwave power required to maintain the desiredtreatment temperature declines following the first orsecond treatment of a given field. Final ly, i t appears thattumor regression following completion of treatment isvery s low and requires approximately two months beforethe total effect is obtained.

    DISCUSSIONAlthough it is still very early in this study and longterm follow-up is not available yet, it is clear this treat-ment regime does produce striking results in a widevariety of cases. If only tho se fields which were treated

    com pletely and available for fol low-up are co nsidered, wecan repor t 67 .6% total respo nse, 29.7% p ar t ia l responseand only 2.7% no response. In only one patient has a localrecurrence been no ted; possibly as a result of misal l ignedthermocouples that resulted in artifactual temperaturereadouts. The patient is currently being retreated.

    The observations on power required to maintain aconstant tempera ture and on tumo r regress ion t ime are

    Table 3. Results by histologyFol low

    No. of upfields R e s p o ns e (months)Malignant

    m e l a n o m aMalignantlymphomaSquamous ce l l CAAdenocarcinomaS a r comaGliomaOthe r(basal cell,transitional cell)

    4 3 Total 21 Partia l 25 5 Tota l 3-6

    6 3 Total 23 Partial17 12 Tota l 2-55 Partial2 1 Partia l-expired --1 No response Partial 42 2 Tota l 2-4

    Total response: no tumor present at 2 months follow-up andthereafter.Partial response: Tumor decreased in size to half or less at 2months follow-up.Partia l response--Exp ired: Patient deceased during or within 8weeks after treatment.both quite interesting. Based on recent laboratory results ,it is likely that both phenomena are related to heatinduced, physiological changes within the tumor whichare involved in the ultimate destruction of the tumor.Further physiolog ical s tudies are currently in prog ress .

    I t is also interesting to sp eculate on the po ssible m ean-ing of the two marginal recurrences; they may indicatethat this combined modality protocol is effective in thet reatmen t of m icroscopic disease. More t ime for fo l low-up and the input of m ore p at ients wi l l be required beforea t rue evaluat ion o f the c l in ica l eff icacy of th is proto colcan be made.

    REFERENCES1. Brenner , H.J. , Yerushalmi, A. : Combined local hyperther-mia and x-irradiation in the treatment of metastatictumors . Br. J . Cancer 33: 91- 95 , 1975 .2 Bruns, P. : Die heilwirung des erysipels auf geschwulste .Beitr Klin Chir 3: 443- 466, 188 7.3. Busch, W .: Uber den Einfluss welchen heftigere Erysipelnzuweilen auf organistier te Ne ubildungen ausueben. Ver-hand l . Naturh. Preuss. Thein. Westpahl . 23: 28-30, 1866.4. Cavaliere, R., Ciocatto, E.C., Giovanella, B.C., Heidel-berger, C., Johnson, R.O., Margottini, M., Mondovi, B.,Mo ricca, G., Rossi-Fanelli, A.: Selective heat sensitivity for

    cancer cells. Cancer Philad. 20: 1351-1381, 1967.5. Coley, W.B.: The treatment of malignant tumors byrepeated inocula tions of er ispe las with a repor t of o r igina lcases. Am. J. Med. Sci. 105:487 512, 1893.6. C rile , G. Jr. : Heat as an adjunct to the treatm ent of cancer .Cleveland Clin. 28: 75-89, 1961.

    7. Crile, G.J.: The effect of heat and radiation on cancersimplanted on the feet of mice. Cancer Res . 23: 372-380,1 9 6 3 .8. Day, P.W., Sternhagen, C.J., Doss, J.D., Edwards, S.:Co mbination radiation therap y and localized current fie ld

    hyperthermia of spontaneous malignant neoplasms ofanimals. A preclinical study, presented at the AmericanSocie ty of Therapeut ic Radio logis ts, 18th Ann ua l Meet-ing . At lanta , Georgia , Oct . , 16 , 1976 .9. Doss, J.D., McCabe, C.W.: A technique for localizedheating in t issue , an adjunct to tumo r therapy. Med. Instr .10: 133-136, 1975.10 . Gerweck, L.E.: Modification of cell lethality at elevatedtemperatures. The pH effect. Radiat. Res. 70: 224-235,1977 .11 . Hartman, J.T., Crile, G.C., Jr.: Heat treatment of osteo-genic sarcoma, R epor t o f f ive cases. Clin Orth Rel Res61: 269-276, 1968.12 . Hornback, N.B., Shupe, R,E~, Homayoon, S., Joe, B.T.,Edgardo, S., Marshall, C.~ ~~liminary clinical results ofcom bined433 m egaher tz r~iizrowave therapy and radia tiontherapy on patients with advanced cancer. Cancet~.~40:2854-2863, 1977.i3. Johnson, R.J.R., Sandhu, T.S., Hetzel, F.W., Kowal, H.S.,Bicher, H.I., Song, S.: A pilot study to investigate thetherapeutic ratio of hyperthermia 41.5-42.0C and radia-tion. In t . J . Rad iat . Oncol . Biol . Phys . 5:947 954, 1979.

  • 8/14/2019 0210_HYPERTHERMIA & RADIATION IN COMBINATION_ A CLINICAL FRACTIONATION REGIME - 08.pdf

    4/4

    87014 .

    Radiat ion Oncology Biology PhysicsLeveen, H.H., Wapnick, S., Piccone, V., Fald, G., Ahmed,N.: Tumor eradication by radiofrequency therapy. J A M A235: 2198-2200, 1976.15. Moricca, G., Cavaliere, R., Caputo, A., Bigotti, A., Colis-tro, F: Hyperthermic treatment of tumors: Experimentaland clinical applications. Rec . Res . Cancer R es . 59:112-1 5 2 , 1 9 7 7 .16 . Sandhu , T .S . , Kowal , H . , Johnson, R .J .: The deve lopm entof microwave hyperthermia applicators. Int. J. Radiat.On c . B io l . Phys . 4: 515-519, 1978.17 . Sternhagen, C.J., Doss, J.D., Day, P.W., Edwards, W.S.,Doberneck, R.C., Herzon, F.S., Powell, T.D., OBrien,G.F. , Larkin, J .J . : Clinical use of radio frequency current in

    July 1980 , Volume 6 , Number 7

    18 .19 .20 .

    oral cavity carcinomas and metastatic malignancies withcontinuous temperature control and mo nitor ing. In Proc . o fSecond Annua l In t . Symp. on C an . Thera . by Hyper ther -m i a a n d R a d . C. Streffer (Ed.) Baltimore-Munich, Urban& Schwarzenb erg Inc . 1978, p p . 331- 334 .Suit, H.D.: Hyperthermic effects on animal tissues. Radi-ology 123: 483-487, 1977.Suit, H.D., Shwayder, M.: Hyperthermia: Potential as ananti-tumor agent. Cancer 34:122-129, 1974.W estra , A. , D ewey, W .C. : V ar ia tion in sensi tiv ity to hea tshock during the cell cycle of chinese hamster cells in vitro.Int. J. Radiat. Biol. 19: 467- 47 7, 1971.